Bajaj Healthcare

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE411U01027
NSEID: BAJAJHCARE
BSEID: 539872
View on NSE | View on BSE

INR

320.10

-1.45 (-0.45%)

BSENSE

Aug 25, 03:30 PM

BSE+NSE Vol: 43.23 k

Access older stock analysis version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Lincoln Pharma.

Kopran

Wanbury

Sigachi Indust.

Anlon Healthcare

Fermenta Biotec.

Bajaj Healthcare

Themis Medicare

Bharat Parenter.

Accent Microcell

Remus Pharma.

Why is Bajaj Healthcare Ltd ?

Low ability to service debt as the company has a high Debt to EBITDA ratio of 2.80 times

Low ability to service debt as the company has a high Debt to EBITDA ratio of 2.80 times

Poor long term growth as Net Sales has grown by an annual rate of -2.23% and Operating profit at -8.94% over the last 5 years

Flat results in Jun 26

Falling Participation by Institutional Investors

Institutional investors have decreased their stake by -0.78% over the previous quarter and collectively hold 4.11% of the company
These investors have better capability and resources to analyse fundamentals of companies than most retail investors

Underperformed the market in the last 1 year

Even though the market (BSE500) has generated returns of 1.95% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -26.78% returns

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Bajaj Healthcare for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Bajaj Healthcare

-27.01%

-0.61

44.56%

Sensex

-4.88%

-0.36

13.50%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-2.23%

EBIT Growth (5y)

-8.94%

EBIT to Interest (avg)

3.64

Debt to EBITDA (avg)

2.79

Net Debt to Equity (avg)

0.46

Sales to Capital Employed (avg)

0.97

Tax Ratio

25.35%

Dividend Payout Ratio

8.00%

Pledged Shares

Institutional Holding

4.11%

ROCE (avg)

13.99%

ROE (avg)

15.14%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.21

EV to EBIT

16.23

EV to EBITDA

11.92

EV to Capital Employed

1.83

EV to Sales

2.07

PEG Ratio

1.80

Dividend Yield

0.29%

ROCE (Latest)

8.13%

ROE (Latest)

11.49%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bullish

Bearish

Dow Theory

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

PAT(Latest six months)

At Rs 31.33 cr has Grown at 28.09%

NET SALES(Q)

Highest at Rs 165.63 cr

0What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Loading Valuation Snapshot...

Here's what is working for Bajaj Healthcare

Profit After Tax (PAT) - Latest six months

At Rs 31.33 cr has Grown at 28.09%

Year on Year (YoY)

MOJO Watch

Near term PAT trend is positive

PAT (Rs Cr)

Net Sales - Quarterly

Highest at Rs 165.63 cr

in the last five quarters

MOJO Watch

Near term sales trend is positive

Net Sales (Rs Cr)